Aemetis (NASDAQ:AMTX) Raised to “Sell” at StockNews.com

StockNews.com upgraded shares of Aemetis (NASDAQ:AMTX) to a sell rating in a research report sent to investors on Wednesday.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research note on Monday, December 23rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, Aemetis has an average rating of “Moderate Buy” and an average target price of $12.95.

Aemetis Price Performance

AMTX opened at $2.11 on Wednesday. The stock’s 50 day simple moving average is $2.82 and its 200 day simple moving average is $2.86. The firm has a market cap of $104.95 million, a price-to-earnings ratio of -0.93 and a beta of 1.44. Aemetis has a 1 year low of $2.04 and a 1 year high of $7.03.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.47) by $0.09. The firm had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same quarter in the prior year, the business posted ($0.59) EPS. As a group, sell-side analysts anticipate that Aemetis will post -2.07 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in AMTX. State Street Corp boosted its stake in shares of Aemetis by 36.1% during the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock valued at $1,608,000 after purchasing an additional 185,304 shares in the last quarter. Wellington Management Group LLP purchased a new stake in Aemetis in the third quarter worth about $177,000. Geode Capital Management LLC boosted its position in Aemetis by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock valued at $2,126,000 after acquiring an additional 66,031 shares in the last quarter. Barclays PLC grew its holdings in shares of Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after acquiring an additional 34,816 shares during the period. Finally, SG Americas Securities LLC bought a new position in shares of Aemetis in the 4th quarter worth approximately $87,000. 27.02% of the stock is currently owned by institutional investors.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.